NCT01268644View on ClinicalTrials.gov

Effects of Metreleptin in Type 1 Diabetes Mellitus

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

August 31, 2014

Conditions
Type 1 Diabetes
Interventions
DRUG

Leptin

weight based sub-cutaneous injection twice daily of Leptin

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER